# Booz Allen Hamilton Holding Corp: overview

BAH · NYSE · CIK 1443646 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/bah.md) · [Financials](/companies/bah/financials.md) · [Filings](/companies/bah/filings.md) · [Insiders](/companies/bah/insiders.md)

Latest reported revenue: [$2.78bn](/filings/0001628280-26-066973.md) for Q2 FY2027, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-066973).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | Q2 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,917](/filings/0001628280-26-003187.md) | [2,975 d](/filings/0001628280-26-037521.md) | [2,924](/filings/0001628280-26-049495.md) | [2,890](/filings/0001628280-26-066973.md) | [2,620](/filings/0001628280-26-003187.md) | [2,783 d](/filings/0001628280-26-037521.md) | [2,800](/filings/0001628280-26-049495.md) | [2,778](/filings/0001628280-26-066973.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.0%](/filings/0001628280-26-003187.md) | [9.2% d](/filings/0001628280-26-037521.md) | [8.8%](/filings/0001628280-26-049495.md) | [9.8%](/filings/0001628280-26-066973.md) | [8.8%](/filings/0001628280-26-003187.md) | [9.5% d](/filings/0001628280-26-037521.md) | [10.0%](/filings/0001628280-26-049495.md) | [8.8%](/filings/0001628280-26-066973.md) |
| Net margin | % | [6.4%](/filings/0001628280-26-003187.md) | [6.5% d](/filings/0001628280-26-037521.md) | [9.3%](/filings/0001628280-26-049495.md) | [6.1%](/filings/0001628280-26-066973.md) | [7.6%](/filings/0001628280-26-003187.md) | [7.4% d](/filings/0001628280-26-037521.md) | [7.1%](/filings/0001628280-26-049495.md) | [6.5%](/filings/0001628280-26-066973.md) |
| Diluted EPS | $ per share | [1.45](/filings/0001628280-26-003187.md) | not reported | [2.16](/filings/0001628280-26-049495.md) | [1.42](/filings/0001628280-26-066973.md) | [1.63](/filings/0001628280-26-003187.md) | not reported | [1.63](/filings/0001628280-26-049495.md) | [1.50](/filings/0001628280-26-066973.md) |
| Free cash flow | $m | [134 d](/filings/0001628280-26-003187.md) | [194 d](/filings/0001628280-26-037521.md) | [96.0](/filings/0001628280-26-049495.md) | [395 d](/filings/0001628280-26-066973.md) | [248 d](/filings/0001628280-26-003187.md) | [212 d](/filings/0001628280-26-037521.md) | [261](/filings/0001628280-26-049495.md) | [263 d](/filings/0001628280-26-066973.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.4](/filings/0001443646-24-000075.md) | [9.3](/filings/0001443646-25-000076.md) | [10.7](/filings/0001628280-26-037521.md) | [12.0](/filings/0001628280-26-037521.md) | [11.2](/filings/0001628280-26-037521.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [8.2%](/filings/0001443646-24-000075.md) | [4.8%](/filings/0001443646-25-000076.md) | [9.5%](/filings/0001628280-26-037521.md) | [11.4%](/filings/0001628280-26-037521.md) | [9.2%](/filings/0001628280-26-037521.md) |
| Net margin | % | [5.6%](/filings/0001443646-24-000075.md) | [2.9%](/filings/0001443646-25-000076.md) | [5.7%](/filings/0001628280-26-037521.md) | [7.8%](/filings/0001628280-26-037521.md) | [7.6%](/filings/0001628280-26-037521.md) |
| Diluted EPS | $ per share | [3.44](/filings/0001443646-24-000075.md) | [2.03](/filings/0001443646-25-000076.md) | [4.59](/filings/0001628280-26-037521.md) | [7.25](/filings/0001628280-26-037521.md) | [6.90](/filings/0001628280-26-037521.md) |
| Free cash flow | $bn | [0.7](/filings/0001443646-24-000075.md) | [0.5](/filings/0001443646-25-000076.md) | [0.2](/filings/0001628280-26-037521.md) | [0.9](/filings/0001628280-26-037521.md) | [1.0](/filings/0001628280-26-037521.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bah/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $804.9m | 13,266,423 |  | Added +781,823 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $446.4m | 7,358,547 |  | Reduced −514,389 |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $388.1m | 6,397,644 |  | Added +1,567,846 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $328.0m | 5,405,478 |  | Added +8,100 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $242.3m | 3,993,220 |  | Added +381,771 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $240.4m | 3,961,727 |  | Added +3,072,138 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $233.7m | 3,851,331 |  | Added +55,445 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $178.6m | 2,873,404 |  | Added +70,086 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $178.1m | 2,935,408 |  | Added +270,870 |
| [Black Creek Investment Management Inc.](/funds/1528593.md) | 2026-06-30 | $173.8m | 2,864,545 |  | Added +206,178 |

## Recent filings

[All 1,423 filings](/companies/bah/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 06:52 ET | [10-Q](/filings/0001628280-26-066973.md) | Quarterly report, period 2026-09-30 | 0001628280-26-066973 |
| 2026-10-23 | 06:48 ET | [8-K](/filings/0001628280-26-066971.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-066971 |
| 2026-08-24 | 08:31 ET | [8-K](/filings/0001443646-26-000058.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001443646-26-000058 |
| 2026-08-04 | 16:50 ET | [8-K](/filings/0001104659-26-090450.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-090450 |
| 2026-07-24 | 16:15 ET | [8-K](/filings/0001443646-26-000029.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001443646-26-000029 |
| 2026-07-24 | 06:50 ET | [10-Q](/filings/0001628280-26-049495.md) | Quarterly report, period 2026-06-30 | 0001628280-26-049495 |
| 2026-07-24 | 06:49 ET | [8-K](/filings/0001628280-26-049494.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049494 |
| 2026-06-22 | 08:05 ET | [8-K](/filings/0001104659-26-076094.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-076094 |
| 2026-06-11 | 16:16 ET | [DEF 14A](/filings/0001443646-26-000021.md) | Proxy statement, period 2026-07-22 | 0001443646-26-000021 |
| 2026-05-22 | 06:52 ET | [10-K](/filings/0001628280-26-037521.md) | Annual report, period 2026-03-31 | 0001628280-26-037521 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001628280-26-037521.md), filed May 22, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1443646
- Tickers: BAH
- Exchange: NYSE
- SIC code: 8742 Services-Management Consulting Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:30 ET. No prices; not investment advice.